4870 Sadler Road
Suite 300
Richmond, VA  23060
(804) 934-0282

Guidelines and Grant Process

Funding Priorities
  • Patient Centric approach to transfusion medicine decision making.

  • Responsible, evidence-based regulatory constructs.

  • Timely, safe, and reliable access to blood products for all patients. 

  • Appropriate attention to donor safety measures.

  • Better understanding of the supply chain and economics underpinning the blood industry.

CTF will not consider:
  • Unrestricted grants

  • Grants to for-profit organizations

  • Grants to private grant making foundations

  • Grants to individuals

  • Grants for projects that are not generalizable to the field of transfusion medicine (e.g. grant requests that only benefit a single organization or, limited population)

  • Grants for operational expenses

  • Grants for purchase of or replacement of any capital equipment

  • Grants for general fundraising

  • Grants for building or renovation projects

  • Grants to support political campaigns or lobbying efforts

  • Grants that do not support the Foundation’s mission

  • Grants to promote religious doctrine or tenets

  • Grants for organization startup or seed funding

  • Flat percentage cost add-ons (e.g. F&A)

  • Grants for projects where the Grantee is unwilling to openly share results

Generally speaking, CTF does not consider grant requests that exceed $250,000 in any single year. Applicants that have requests that exceed this amount may discuss their proposal with CTF staff prior to submitting a Letter of Inquiry.

Important Dates

Letters of Inquiry (LOI) may be submitted at any time and are reviewed by the Foundation’s Grants Committee on an ongoing basis. Formal applications are considered twice a year in May and October and are by invitation only. We encourage applicants to submit LOIs early in the grant cycle to avoid a last minute rush, and to ensure that your letter can be given complete consideration.

If you submit an LOI late in the cycle, we cannot guarantee that you will receive a response in time to prepare and submit a formal application to be considered for that grant cycle.

Deadlines to submit a formal application (for invited applicants only) are January 25 and July 26 each year.

Submission Process

Please review Commonwealth Transfusion Foundation’s Guidelines and Grant Agreement prior to submitting an LOI.

Step One
Potential grantees submit a Letter of Inquiry (LOI) through the CTF on-line grants management portal. LOIs will be reviewed by the Grant’s Committee and — at the Committee’s discretion — by an External Review Committee. Selected applicants will be invited to submit a full proposal. The invitation to submit and/or acceptance of a formal application should not be construed as a conference of a grant by the Foundation.

Step Two
Invited applicants will submit applications via the CTF on-line grants management portal. The Application will be reviewed by the Grant’s Committee and – at the Committee’s discretion — by an External Review Committee.

Step Three
Applicants are notified of the Grant’s Committee decision.

Step Four
Applicant and CTF execute a Grants Agreement. Funds cannot be disbursed until this agreement is fully executed.

Step Five
Funds are disbursed in accordance with the terms of the Grants Agreement.

External Review Committee

Similar to a peer review journal, CTF uses a panel of transfusion experts from around the country to review grant applications at the Grant’s Committee’s discretion. The External Review Committee is comprised of a well-rounded group of professionals that are actively involved in transfusion medicine research, education, and practice. The External Review Committee provides feedback to the Grant’s Committee regarding Letters of Inquiry and Grant Applications; however, the final decision regarding approval or denial of an application lies with the CTF Grant’s Committee.

Grant applicants should not attempt to contact members of the External Review Committee regarding Letters of Inquiry or Applications. Contact with an External Reviewer may result in disqualification the LOI or application.